Microtubule-binding agents: a dynamic field of cancer therapeutics
C Dumontet, MA Jordan - Nature reviews Drug discovery, 2010 - nature.com
Microtubules are dynamic filamentous cytoskeletal proteins composed of tubulin and are an
important therapeutic target in tumour cells. Agents that bind to microtubules have been part …
important therapeutic target in tumour cells. Agents that bind to microtubules have been part …
Strategies and challenges for the next generation of antibody–drug conjugates
A Beck, L Goetsch, C Dumontet… - Nature reviews Drug …, 2017 - nature.com
… c | The second-generation ADC brentuximab vedotin is a conjugate of a chimeric IgG1
mAb specific for CD30 and 4 monomethyl auristatin E (MMAE) moieties per IgG, which are …
mAb specific for CD30 and 4 monomethyl auristatin E (MMAE) moieties per IgG, which are …
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
…, D Durantel, F Zoulim, C Dumontet - Nature reviews Drug …, 2013 - nature.com
… New interferon-free regimens to cure hepatitis C virus infection are likely to contain a potent
and pan-genotypic active nucleoside or nucleotide analogue. Two of these — sofosbuvir …
and pan-genotypic active nucleoside or nucleotide analogue. Two of these — sofosbuvir …
[HTML][HTML] Lenalidomide maintenance after stem-cell transplantation for multiple myeloma
…, M Michallet, B Pegourie, C Dumontet… - … England Journal of …, 2012 - Mass Medical Soc
Background High-dose chemotherapy with autologous stem-cell transplantation is a standard
treatment for young patients with multiple myeloma. Residual disease is almost always …
treatment for young patients with multiple myeloma. Residual disease is almost always …
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
…, AM Stoppa, JJ Sotto, M Wetterwald, C Dumontet… - Blood, 2007 - ashpublications.org
Acquired genomic aberrations have been shown to significantly impact survival in several
hematologic malignancies. We analyzed the prognostic value of the most frequent …
hematologic malignancies. We analyzed the prognostic value of the most frequent …
Nucleoside analogues: mechanisms of drug resistance and reversal strategies
CM Galmarini, JR Mackey, C Dumontet - Leukemia, 2001 - nature.com
Nucleoside analogues (NA) are essential components of AML induction therapy (cytosine
arabinoside), effective treatments of lymphoproliferative disorders (fludarabine, cladribine) …
arabinoside), effective treatments of lymphoproliferative disorders (fludarabine, cladribine) …
Nucleoside analogues and nucleobases in cancer treatment
CM Galmarini, JR Mackey, C Dumontet - The lancet oncology, 2002 - thelancet.com
Cytotoxic nucleoside analogues and nucleobases were among the first chemotherapeutic
agents to be introduced for the medical treatment of cancer. This family of compounds has …
agents to be introduced for the medical treatment of cancer. This family of compounds has …
[HTML][HTML] Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial
…, TO Nielsen, CM Perou, C Dumontet… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
… Certain relationships marked with a “U” are those for which no compensation was received;
those relationships marked with a “C” were compensated. For a detailed description of the …
those relationships marked with a “C” were compensated. For a detailed description of the …
Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed
C Thieblemont, F Berger, C Dumontet… - Blood, The Journal …, 2000 - ashpublications.org
Mucosa-associated lymphoid tissue–derived lymphoma (MALT lymphoma) is usually a very
indolent lymphoma, described as localized at diagnosis and remaining localized for a …
indolent lymphoma, described as localized at diagnosis and remaining localized for a …
[PDF][PDF] Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death
C Dumontet, BI Sikic - Journal of Clinical Oncology, 1999 - Citeseer
… The six mammalian beta-tubulin isotypes may be grouped into six classes, according to
their C-terminal amino acid composition, which is the most highly divergent portion between …
their C-terminal amino acid composition, which is the most highly divergent portion between …